UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
A A A+ A- A0 A1 A2 A3 A4 A5 A6 A7 A8 A9 AA AB AC AD AE AF AG AH AI AJ AK AL AM AN AO AP AQ AR AS AT AU AV AW AX AY AZ
AL AL- AL7 ALA ALB ALC ALD ALE ALF ALG ALH ALI ALK ALL ALM ALN ALO ALP ALR ALS ALT ALU ALV ALW ALZ
selected terms: 41 page 1 of 1

1. ALV
[species in the genus Alpharetrovirus, producing latent or manifest lymphoid leukosis in fowl. ( CSP )] (UMLS (CSP) C0004422) =Virus ;
22. alveolar macrophage
[round, granular, mononuclear phagocytes found in the alveoli of the lungs that ingest small inhaled particles resulting in degradation and presentation of the antigen to immunocompetent cells. ( CSP )] (UMLS (CSP) C0085236) =Cell =Histiocyte;
Body System, Pulmonary
2. ALVAC
[A vaccine based upon the ALVAC Canarypox virus vector. ( NCI )] (UMLS (NCI) C0211671) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance; Immunologic Factor
23. ALVEOLAR MANDB HYPOPLSIA
[ ] (UMLS (ICD9CM) C0375350) =Anatomical Abnormality ;
3. ALVAC CEA B7.1 Vaccine
[A cancer vaccine that uses a viral vector system derived from the canarypox virus engineered to target the carcinoembryonic antigen (CEA). It causes infected cells to temporarily display CEA and activates the immune system to attack the tumor cells. ( NCI )] (UMLS (NCI) C1134540) ALVAC-CEA B7.1 Vaccine =Pharmacologic Substance; Immunologic Factor ;
24. ALVEOLAR MANDIB HYPRPLAS
[ ] (UMLS (ICD9CM) C0375348) =Anatomical Abnormality ;
4. ALVAC hB7.1/IFN-G
(UMLS (NCI) C0677795) =Therapeutic or Preventive Procedure
25. ALVEOLAR MAXIL HYPOPLSIA
[ ] (UMLS (ICD9CM) C0375349) =Anatomical Abnormality ;
5. ALVAC-CEA
[A cancer vaccine containing a canary pox virus (ALVAC) combined with the human carcinoembryonic antigen (CEA) gene. ( NCI )] (UMLS (NCI) C0338246) =Pharmacologic Substance; Biologically Active Substance ;
26. ALVEOLAR MAXIL HYPRPLSIA
[ ] (UMLS (ICD9CM) C0375347) =Anatomical Abnormality ;
6. ALVAC-CEA Vaccine/Sargramostim
(UMLS (NCI) C0677999) =Therapeutic or Preventive Procedure
27. Alveolar Pattern
(UMLS (NCI) C1332240) =Finding ;
7. ALVAC-CEA-B7.1 vaccine/Fluorouracil/Irinotecan/Leucovorin calcium
(UMLS (NCI) C1134541) =Therapeutic or Preventive Procedure
28. Alveolar Rhabdomyosarcoma
[A rapidly growing malignant mesenchymal neoplasm. It is characterized by the presence of round cells with myoblastic differentiation and a fibrovascular stroma resembling an alveolar growth pattern. The tumor usually presents in the extremities. ( NCI )] (UMLS (NCI) C0206655) =Neoplastic Process =rhabdomyoblastoma;
8. ALVAC-CEA-B7.1 vaccine/Fluorouracil/Irinotecan/Leucovorin calcium/Tetanus toxoid
(UMLS (NCI) C1134542) =Therapeutic or Preventive Procedure
29. Alveolar Rhabdomyosarcoma of Orbit
[A malignant mesenchymal neoplasm that arises in the orbit. It is characterized by the presence of round cells with myoblastic differentiation and a fibrovascular stroma. ( NCI )] (UMLS (NCI) C1335126) Alveolar Rhabdomyosarcoma of the Orbit;
Orbit Alveolar Rhabdomyosarcoma;
=Neoplastic Process ;
9. ALVAC-CEA-B7.1 Vaccine/Tetanus Toxoid
(UMLS (NCI) C1327928) =Therapeutic or Preventive Procedure; ;
30. Alveolar Sac
[The terminal dilation of an alveolar duct that gives rise to alveoli in the lung. ( NCI )] (UMLS (NCI) C0225691) =Body Part, Organ, or Organ Component
10. ALVAC-hB7.1
[A vaccine comprise of a canarypox viral vector that carries the gene for human B7.1 (CD80 antigen) with potential use as an autologous therapeutic cancer vaccine. Tumor cells harvested from a patient are infected with ALVAC-hB7 1, thereby producing an autologous cell line that exhibits increased expression of HLA class I and class II, CD54 (ICAM), and CD80. Increased expression of these proteins by this autologous cell line may activate an antitumor T-cell response when the modified cells are administered to the patient. (NCI04) ( NCI )] (UMLS (NCI) C0796294) =Pharmacologic Substance; Immunologic Factor
31. Alveolar Soft Part Sarcoma
[A rare malignant neoplasm characterized by the presence of large epithelioid cells with abundant cytoplasm forming nests and pseudoalveolar structures. The groups of the epithelioid cells are separated by thin-walled sinusoidal spaces. It occurs most often in adolescents and young adults. In adults, the most common sites of involvement are the extremities, and in infants and children the head and neck. It usually presents as a slowly growing mass and it frequently metastasizes to other anatomic sites. The most common sites of metastasis are the lungs, bone, and brain. ( NCI )] (UMLS (NCI) C0206657) =Neoplastic Process =Neoplasms, Muscle Tissue;
Connective Tissue Sarcoma
11. ALVAC-hB7.1/Canarypox-hIL-12 Melanoma Vaccine
(UMLS (NCI) C0796341) =Therapeutic or Preventive Procedure
32. Alveolar Soft Part Sarcoma Metastatic
[Alveolar soft part sarcoma spreading to another site ( NCI )] (UMLS (NCI) C0855036) Metastatic Alveolar Soft Part Sarcoma;
=Neoplastic Process
12. ALVAC-hIL-12
[A vaccine consisting of a replication-defective recombinant canarypox virus (ALVAC) that encodes the gene for human interleukin-12 (hIL-12). Produced mainly by B-cells, IL-12 is an endogenous cytokine that activates natural killer (NK) cells, promotes cytotoxic T lymphocyte (CTL) responses, induces the release of interferon-gamma (IFN-gamma), and may exhibit antitumor and anti-angiogenic effects. Vaccination with canarypox-hIL-12 melanoma vaccine may stimulate the host immune system to mount an immune response against tumor cells, thereby inhibiting tumor growth and/or metastasis. (NCI04) ( NCI )] (UMLS (NCI) C0677735) =Pharmacologic Substance; Immunologic Factor
33. Alveolar Soft Part Sarcoma Nonmetastatic
[An alveolar soft part sarcoma presently contained in the anatomical site where it initially manifested. ( NCI )] (UMLS (NCI) C0855037) Non-Metastatic Alveolar Soft Part Sarcoma;
Primary Alveolar Soft Part Sarcoma =Neoplastic Process
13. ALVEOL PNEUMONOPATHY NEC
(UMLS (ICD9CM) C0155913) =Disease or Syndrome ;
34. Alveolar Soft Part Sarcoma Recurrent
[The reemergence of alveolar soft part sarcoma after a period of remission. ( NCI )] (UMLS (NCI) C0855038) Recurrent Alveolar Soft Part Sarcoma;
Relapsed Alveolar Soft Part Sarcoma =Neoplastic Process
14. ALVEOL PNEUMONOPATHY NOS
(UMLS (ICD9CM) C0155914) =Disease or Syndrome ;
35. Alveolar Wall
(UMLS (NCI) C0225695) =Body Part, Organ, or Organ Component
15. Alveolar border of body of mandible closed fracture
[ ] (UMLS (ICD9CM) C0159331) =Injury or Poisoning
36. Alveolitis
(UMLS (NCI) C0549493) =Disease or Syndrome ;
16. Alveolar border of body of mandible open fracture
[ ] (UMLS (ICD9CM) C0159342) =Injury or Poisoning
37. ALVEOLITIS OF JAW
[A condition sometimes occurring after tooth extraction, particularly after traumatic extraction, resulting in a dry appearance of the exposed bone in the socket, due to disintegration or loss of the blood clot. It is basically a focal osteomyelitis without suppuration and is accompanied by severe pain (alveolalgia) and foul odor. (Dorland, 28th ed) ( MSH )] (UMLS (ICD9CM) C0013240) =Disease or Syndrome =Mouth Diseases;
17. Alveolar Cell Type I
[A flattened cell of the alveolar epithelium, distinguished by their greatly attenuated cytoplasm and paucity of organelles. ( NCI )] (UMLS (NCI) C0225699) =Cell
38. ALVEOLOPLASTY
[Surgical preparation of the alveolar ridges, commonly for the reception of dentures. ( NCI )] (UMLS (ICD9CM) C0002393) =Therapeutic or Preventive Procedure
18. Alveolar Cell Type II
[A pleomorphic cell of the pulmonary alveolar epithelium that secretes surfactant and is distinguished by abundant cytoplasm containing numerous lipid-rich multilamellar bodies. ( NCI )] (UMLS (NCI) C0225700) =Cell
39. ALVEOLUS BIOPSY
[ ] (UMLS (ICD9CM) C0176407) =Diagnostic Procedure
19. Alveolar Childhood Rhabdomyosarcoma
[An aggressive malignant mesenchymal neoplasm occurring in children. It is characterized by the presence of round cells with myoblastic differentiation, and a fibrovascular stroma resembling an alveolar growth pattern. ( NCI )] (UMLS (NCI) C0279613) =Neoplastic Process
40. Alveus
(UMLS (NCI) C0228247) =Body Part, Organ, or Organ Component
20. Alveolar Duct
[The respiratory passage distal to the respiratory bronchiole. Alveolar sacs and alveoli arise from the alveolar duct. ( NCI )] (UMLS (NCI) C0391892) =Body Part, Organ, or Organ Component ;
41. Alvimopan
[A synthetic trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine with peripherally selective opioid mu receptor antagonist activity. Alvimopan is a selective and competitive antagonist at mu-opioid receptors, found in myenteric and submucosal neurons and the immune cells of the lamina propria in the human gut. Upon administration, this agent binds to mu-opioid receptors in the gut, thereby reversing opioid-related disturbances in gut motility. Alvimopan is approximately three to nine times more potent than naloxone. ( NCI )] (UMLS (NCI) C1508750) =Organic Chemical; Pharmacologic Substance
21. alveolar epithelium
[Epithelia of lung alveoli. The layer of cells covering the lining of the tiny air sacs at the end of the bronchioles. ( NCI )] (UMLS (CSP) C0225694) =Tissue

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM